Next year twenty-eight drugs relevant to workers’ compensation are expected to become available as generics. These formulations will be made available once the original drug manufacturer’s brand name period of exclusivity has expired.
According to the FDA, 9 out of 10 prescriptions filled in the United States are for generic drugs. Brand drugs with equivalent generic formulations are an essential category to monitor, as these drugs are by far the most expensive. Prescriber education surrounding the use of generics is increasingly key when prescribers or patients request brand drugs as more generics become available.
The following table provides information on drugs expected to be approved as generic equivalents in 2022. At the time of this publication generic pricing was not available.